Literature DB >> 21177296

Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort.

Anne Durnez1, Geert Vanderschueren, Luc Lateur, René Westhovens, Patrick Verschueren.   

Abstract

OBJECTIVES: To evaluate expert treatment selection for early rheumatoid arthritis and to validate a prediction model for rapid radiographic progression (RRP) in daily practice.
METHODS: Patients received initial combination therapy with steroids (ICTS) or disease-modifying antirheumatic drug monotherapy (IMT) after informal evaluation of prognostic factors, followed by a tight control strategy. Changes in Sharp/van der Heijde score (total Sharp score (TSS)) of >5 units over 1 year (=RRP) were documented. The mean change in TSS and proportion with RRP were compared between groups. Based on the 28 swollen joint count, rheumatoid factor titre and C reactive protein/erythrocyte sedimentation rate, patients were placed in the ASPIRE prediction matrix, yielding a RRP risk. Numbers needed to treat (NNT) intensively to avoid one RRP after 1 year were calculated.
RESULTS: The mean change in TSS after 1 year and the proportion with RRP was lower in the ICTS group (n=37) than in the IMT group (n=43). The mean calculated risk of RRP was higher in patients with radiographic progression. The mean NNT intensively to prevent RRP was lower in the ICTS group than in the IMT group. The positive predictive value of NNT for RRP prevention was 12.6%, but the negative predictive value reached 100%.
CONCLUSION: ICTS seems more effective in preventing RRP than IMT. The predictive matrix model could be helpful in preventing overtreatment in practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177296     DOI: 10.1136/ard.2010.135319

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Two-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice.

Authors:  D De Cock; G Vanderschueren; S Meyfroidt; J Joly; R Westhovens; P Verschueren
Journal:  Clin Rheumatol       Date:  2014-01       Impact factor: 2.980

Review 2.  Risk estimation in rheumatoid arthritis: from bench to bedside.

Authors:  Annette H M van der Helm-van Mil
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543

3.  Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.

Authors:  Siri Lillegraven; Nina Paynter; Femke H M Prince; Nancy A Shadick; Espen A Haavardsholm; Michelle L Frits; Christine K Iannaccone; Tore K Kvien; Michael E Weinblatt; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

Review 4.  cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.

Authors:  Patrick Vandormael; Patrick Verschueren; Liesbeth De Winter; Veerle Somers
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.

Authors:  John M Davis; Keith L Knutson; John A Skinner; Michael A Strausbauch; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Eric L Matteson; Sherine E Gabriel
Journal:  Arthritis Res Ther       Date:  2012-01-31       Impact factor: 5.156

6.  Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.

Authors:  Bruno Fautrel; Benjamin Granger; Bernard Combe; Alain Saraux; Francis Guillemin; Xavier Le Loet
Journal:  Arthritis Res Ther       Date:  2012-11-19       Impact factor: 5.156

7.  Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients.

Authors:  Edit Végh; János Gaál; Pál Géher; Edina Gömöri; Attila Kovács; László Kovács; Katalin Nagy; Edit Feketéné Posta; László Tamási; Edit Tóth; Eszter Varga; Andrea Domján; Zoltán Szekanecz; Gabriella Szűcs
Journal:  BMC Musculoskelet Disord       Date:  2021-04-02       Impact factor: 2.362

8.  Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial.

Authors:  Saedis Saevarsdottir; Hamed Rezaei; Pierre Geborek; Ingemar Petersson; Sofia Ernestam; Kristina Albertsson; Kristina Forslind; Ronald F van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2014-04-04       Impact factor: 19.103

9.  Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.

Authors:  Benjamin Granger; Bernard Combe; Xavier Le Loet; Alain Saraux; Francis Guillemin; Bruno Fautrel
Journal:  RMD Open       Date:  2016-05-20

Review 10.  Can Synovial Pathobiology Integrate with Current Clinical and Imaging Prediction Models to Achieve Personalized Health Care in Rheumatoid Arthritis?

Authors:  Frances Claire Humby; Farida Al Balushi; Gloria Lliso; Alberto Cauli; Costantino Pitzalis
Journal:  Front Med (Lausanne)       Date:  2017-05-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.